Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Caribou Biosciences Inc shares valued at $20,400 were purchased by Haurwitz Rachel E. on Mar 14 ’25. At $1.02 per share, Haurwitz Rachel E. acquired 20,000 shares. The insider’s holdings grew to 3,369,395 shares worth approximately $3.2 million following the completion of this transaction.
Also, MCCLUNG BARBARA G sold 3,564 shares, netting a total of over 4,811 in proceeds. Following the sale of shares at $1.35 each, the insider now holds 443,502 shares.
Before that, Khan Ruhi Ahmad had sold 3,564 shares from its account. In a trade valued at $4,811, the Chief Business Officer traded Caribou Biosciences Inc shares for $1.35 each. Upon closing the transaction, the insider’s holdings decreased to 3,564 shares, worth approximately $63589.2.
As published in a research note from Evercore ISI on June 03, 2024, Caribou Biosciences Inc [CRBU] has been rated down from an Outperform to an In-line and the price target has been revised to $3 from $13. Analysts at Cantor Fitzgerald started covering the stock with ‘”a Neutral”‘ outlook in a report released in early November. As of October 31, 2023, Evercore ISI has initiated its “an Outperform” rating for CRBU. Earlier on July 11, 2023, Truist initiated its rating. Their recommendation was “a Buy” for CRBU stock.
Analyzing CRBU Stock Performance
During the last five days, there has been a drop of approximately -10.29%. Over the course of the year, Caribou Biosciences Inc shares have dropped approximately -40.19%. Shares of the company reached a 52-week high of $2.0400 on 01/07/25 and a 52-week low of $0.9500 on 03/19/25. A 50-day SMA is recorded $1.3366, while a 200-day SMA reached $1.8410.
Support And Resistance Levels for Caribou Biosciences Inc (CRBU)
According to the 24-hour chart, there is a support level at 0.9381, which, if violated, would cause prices to drop to 0.9254. In the upper region, resistance lies at 0.9755. The next price resistance is at 1.0002. RSI (Relative Strength Index) is 27.49 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0950, which suggests the price will decrease in the coming days. Percent R is at 99.62%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
